Drugs For Neglected Diseases Initiative South Asia Private Limited - Company Profile

It is a pharma foreign private limited company based in New Delhi, Delhi, India, established in 2023.
2023 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Drugs For Neglected Diseases Initiative South Asia Private Limited

Drugs For Neglected Diseases Initiative South Asia Private Limited, a active foreign private limited company, was established on 15 September 2023 in New Delhi, Delhi, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U72100DL2023FTC420081. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.10 Cr and a paid-up capital of ₹1.10 Cr.

Its leadership includes Paul Linus Herrling (Director), Rudi Jose L Paye (Director), Sanjay Sarin (Additional Director). Past directors included Rudi Jose L Paye, Kavita Singh. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at 2Nd Floor, E-13, Hauz Khas, New Delhi, Delhi, 110016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U72100DL2023FTC420081

  • Registration Number

    420081

  • Incorporation Date

    15 September 2023

  • Authorized Capital

    ₹1.10 Cr

  • Paid-Up Capital

    ₹1.10 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.10 Cr
  • Paid Up Capital ₹ 1.10 Cr
  • Company Age 2 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Drugs For Neglected Diseases Initiative South Asia Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Drugs For Neglected Diseases Initiative South Asia Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Drugs For Neglected Diseases Initiative South Asia Private Limited?
Current Directors
Name Designation Appointment Date Status
Paul Linus Herrling Director 15 Sep 2023 Current
Rudi Jose L Paye Director 24 Jan 2024 Current
Sanjay Sarin Additional Director 16 Dec 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 22 Jul 2024 Past
Pramod Abcsdd Director 16 Dec 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Drugs For Neglected Diseases Initiative South Asia.

Enhance accessibility to Drugs For Neglected Diseases Initiative South Asia's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Drugs For Neglected Diseases Initiative South Asia revenue growth over time
Drugs For Neglected Diseases Initiative South Asia profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Drugs For Neglected Diseases Initiative South Asia?

Unlock access to Drugs For Neglected Diseases Initiative South Asia's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Drugs For Neglected Diseases Initiative South Asia?

Unlock and access historical data on people associated with Drugs For Neglected Diseases Initiative South Asia, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Drugs For Neglected Diseases Initiative South Asia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Drugs For Neglected Diseases Initiative South Asia's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Drugs For Neglected Diseases Initiative South Asia
Recent Activity within the Organization
  • Director Appointment

    Sanjay Sarin was appointed as a Additional Director was appointed as a Additional Director on 16 Dec 2025 & has been associated with this company since 2 months 17 days . was recorded as a recent event.

  • Annual General Meeting

    Drugs For Neglected Diseases Initiative South Asia Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Drugs For Neglected Diseases Initiative South Asia Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Director Appointment

    Progress on Rudi Jose L Paye was appointed as a Director was appointed as a Director on 24 Jan 2024 & has been associated with this company since 2 years 1 month . was documented.

  • Director Appointment

    Progress on Paul Linus Herrling was appointed as a Director was appointed as a Director on 15 Sep 2023 & has been associated with this company since 2 years 5 months . was documented.

  • Company Incorporation

    Progress on Drugs For Neglected Diseases Initiative South Asia Private Limited was registered on 15 Sep 2023 with Roc Delhi & aged 2 years 5 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Drugs For Neglected Diseases Initiative South Asia Private Limited?

The CIN of Drugs For Neglected Diseases Initiative South Asia Private Limited is U72100DL2023FTC420081.

Where is Drugs For Neglected Diseases Initiative South Asia Private Limited headquartered?

Drugs For Neglected Diseases Initiative South Asia Private Limited is headquartered at 2Nd Floor, E-13, Hauz Khas, New Delhi, Delhi, 110016.

When was Drugs For Neglected Diseases Initiative South Asia Private Limited incorporated?

Drugs For Neglected Diseases Initiative South Asia Private Limited was incorporated on 15 September 2023.

Who are the current directors of Drugs For Neglected Diseases Initiative South Asia Private Limited?

The current directors of Drugs For Neglected Diseases Initiative South Asia Private Limited are

What is the primary industry of Drugs For Neglected Diseases Initiative South Asia Private Limited?

The primary industry of Drugs For Neglected Diseases Initiative South Asia Private Limited is Pharma.

Is Drugs For Neglected Diseases Initiative South Asia Private Limited a listed company?

Drugs For Neglected Diseases Initiative South Asia Private Limited is unlisted.

What is the capital structure of Drugs For Neglected Diseases Initiative South Asia Private Limited?

The authorized capital of Drugs For Neglected Diseases Initiative South Asia Private Limited is ₹1.10 Cr, and the paid-up capital is ₹1.10 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available